Recent News View All News
Upcoming Events View Events
Investor R&D Day
Jan 31, 2022 • 10:00am - 12:00pm EST
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Register for Ocuphire's upcoming R&D Day on Monday, January 31st
Ocuphire will host a Virtual Investor R&D Day at which six ophthalmic Key Opinion Leaders (KOLs) from retina, optometry and refractive surgery practices will share their thoughts on three large unmet indications, RM, presbyopia, and DR/DME, addressed by Ocuphire’s two late-stage clinical drug assets, Nyxol and APX3330, and provide status updates on their development programs.